Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $18.1 million.

  • Fortress Biotech's Other Non-Current Assets rose 44056.8% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 44056.8%. This contributed to the annual value of $3.3 million for FY2024, which is 2259.57% down from last year.
  • Fortress Biotech's Other Non-Current Assets amounted to $18.1 million in Q3 2025, which was up 44056.8% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Other Non-Current Assets ranged from a high of $18.1 million in Q3 2025 and a low of $1.6 million during Q1 2021
  • In the last 5 years, Fortress Biotech's Other Non-Current Assets had a median value of $3.0 million in 2025 and averaged $3.7 million.
  • In the last 5 years, Fortress Biotech's Other Non-Current Assets crashed by 9009.04% in 2021 and then surged by 44056.8% in 2025.
  • Fortress Biotech's Other Non-Current Assets (Quarter) stood at $2.2 million in 2021, then increased by 21.08% to $2.7 million in 2022, then soared by 59.38% to $4.3 million in 2023, then decreased by 22.6% to $3.3 million in 2024, then soared by 445.3% to $18.1 million in 2025.
  • Its last three reported values are $18.1 million in Q3 2025, $3.0 million for Q2 2025, and $3.1 million during Q1 2025.